PPARA and Hepatitis: Patients with T2DM can develop various complications, including fatty liver and liver inflammation, and dysfunction of hepatic lipid metabolism could be improved by activation of Cpt-1, Hmgcs2, and Pparα to enhance hepatic oxidation and the metabolism of adipose tissue [47–49].